Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.


Creative Commons License

KILIÇKAP S., Öztürk A., KARADURMUŞ N., KORKMAZ T., YUMUK P. F., ÇİÇİN İ., ...Daha Fazla

IASLC 19th World Conference On Lung Cancer, Kanada, 23 - 26 Eylül 2018, cilt.13, ss.1020, (Tam Metin Bildiri)